BDTXBlack Diamond Therapeutics Inc
−12.6% today · −57.1% over a year
No score: too little data.
Quality, Trend, Stability: among the weakest. No dividend.
Black Diamond Therapeutics Inc (BDTX) belongs to the Health care sector and is listed on Nasdaq; country: United States. Its market value is about €85M. Over the past 12 months the price changed by −57.1%, with an annualised volatility of 87% and a largest fall of 67%. Hard red flags in our rules-based screen: Heavy dilution.
Smart Score
How it is scored →Not scored: not enough data for a fair comparison.
Factor scores
Percentiles within the peer group (100 = the best of its peers); dividend safety in points.
Main drivers
- 12-month trend (ex last month)weighs on the score · better than 4% of peers
- Volatility (1 y)weighs on the score · better than 14% of peers
- Betaweighs on the score · better than 6% of peers
Red flags and notes
- Serious warning. Share count growing more than 10 % a year over three years. More in the glossary → Share count growing more than 10 % a year over three years.
- Caution. Negative free cash flow in at least two of the last three years. More in the glossary → Negative free cash flow in at least two of the last three years.
Price chart
Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.
Key metrics
Valuation
- P/B
- 1.0
- Market cap (EUR)
- €85M
Profitability and debt
- Return on equity
- −37.2%
- Return on invested capital
- −57.8%
Dividends
- Dividend yield
- 0.00%
- Years without a lower dividend
- 0
Returns and risk
- 1 day
- −12.6%
- 1 month
- −14.4%
- 1 year
- −57.1%
- Volatility, 1 yr
- 86.9%
- Max drawdown, 1 yr
- −66.9%
- Beta
- 1.73
Ratios from SEC filings and end-of-day prices; returns are price changes without dividends.
Similar companies
Same sector and region, closest in market value.
| LENZLENZ Therapeutics, Inc. | 1/10 | 0.0% | −86.0% |
|---|---|---|---|
| FRNMFreenome Inc. | —/10 | 0.0% | −2.4% |
| VXRTVaxart Inc | —/10 | 0.0% | 12.1% |
| AVXLAnavex Life Sciences Corp. | —/10 | 0.0% | −84.8% |
| ATRAAtara Biotherapeutics Inc | —/10 | 0.0% | −26.0% |
| HCATHealth Catalyst | 1/10 | 0.0% | −50.8% |
| CHRSCoherus Oncology | —/10 | 0.0% | −52.1% |
| ZNTLZentalis Pharmaceuticals | —/10 | 0.0% | 27.6% |
News and filings
No recent news or filings in our sources.
Score changes in the last 12 months
Every published rating and change, logged when it was published (EU Market Abuse Regulation).
Show the log: 3 entries
| Date | Event | Balanced | Growth · Income | Warnings | Price at publication |
|---|---|---|---|---|---|
| Rating change | 1 → —/10 | — · — | — | Available with Invest Pro | |
| Rating change | 1/10 | 1 · — | — | Available with Invest Pro | |
| First rating | —/10 | — · — | Available with Invest Pro |
Ratings are rules-based descriptions, valid until the next scoring run (about 06:20 and 21:50 UTC) and the same for every visitor.
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.